ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KRYS Krystal Biotech Inc

162.83
-0.79 (-0.48%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 144,963
Bid Price 156.84
Ask Price 174.36
News -
Day High 167.12

Low
93.95

52 Week Range

High
189.97

Day Low 162.67
Share Name Share Symbol Market Stock Type
Krystal Biotech Inc KRYS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.79 -0.48% 162.83 19:00:00
Open Price Low Price High Price Close Price Previous Close
163.92 162.67 167.12 162.83 163.62
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,580 144,963 US$ 164.52 US$ 23,849,949 - 93.95 - 189.97
Last Trade Type Quantity Price Currency
15:01:44 26 US$ 162.83 USD

Krystal Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.6B 28.29M - 50.7M 10.93M 0.39 420.99
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Krystal Biotech News

Date Time Source News Article
5/21/202415:38Edgar (US Regulatory)Form 8-K - Current report
5/15/202406:00GlobeNewswire Inc.Krystal Biotech to Present at the American Thoracic Society..
5/08/202406:00GlobeNewswire Inc.Krystal Biotech to Present at BofA Securities 2024 Health..
5/06/202407:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202407:09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on..
5/06/202407:04Edgar (US Regulatory)Form 8-K - Current report
5/06/202407:00GlobeNewswire Inc.Krystal Biotech Announces First Quarter 2024 Financial..
5/02/202406:00GlobeNewswire Inc.Krystal Biotech to Present at the Association for Research..
4/26/202406:00GlobeNewswire Inc.Krystal Biotech to Report First Quarter 2024 Financial..
4/22/202406:00GlobeNewswire Inc.Krystal Biotech Announces First Patient Dosed in Phase 1..
4/04/202406:00GlobeNewswire Inc.Krystal Biotech to Present at the American Association..
3/01/202419:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KRYS Message Board. Create One! See More Posts on KRYS Message Board See More Message Board Posts

Historical KRYS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week164.37174.495160.95165.92237,207-1.54-0.94%
1 Month156.28174.495144.0001160.32271,1296.554.19%
3 Months161.24189.97144.0001168.33325,5771.590.99%
6 Months102.92189.9799.00144.63337,65159.9158.21%
1 Year115.80189.9793.95131.58317,67847.0340.61%
3 Years66.42189.9738.856397.16247,35096.41145.15%
5 Years32.15189.9722.0282.99213,359130.68406.47%

Krystal Biotech Description

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Your Recent History

Delayed Upgrade Clock